Brenda Pursley
Medical · Coffeyville, KSNPI 1316926991
Payments from drug & device makers
Across 104 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$414
- Lilly USA, LLC$191
- Novo Nordisk$154
- Merck$125
- Nestle Healthcare Nutrition Inc.$104
- Sanofi-aventis U.S. LLC$100
- plus $771 from 17 others
What the payments were for
- Food & beverage$1,860100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $414 |
| Lilly USA, LLC | 13 | $191 |
| Novo Nordisk | 8 | $154 |
| Merck | 7 | $125 |
| Nestle Healthcare Nutrition Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 6 | $100 |
| Bayer | 4 | $79 |
| AbbVie | 5 | $77 |
| Sanofi Pasteur Inc. | 3 | $74 |
| Pfizer | 3 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Amgen | 3 | $56 |
| Edwards Lifesciences | 2 | $56 |
| Organogenesis Inc. | 2 | $51 |
| Abbott | 3 | $50 |
| GSK | 3 | $46 |
| Johnson & Johnson | 3 | $36 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Boston Scientific | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$1,860 in reported general payments places this provider in the 65th percentile of 205 medical providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 35 | $36,454 |
| JanuviaSitagliptin Phosphate | 41 | $34,892 |
| XareltoRivaroxaban | 28 | $29,916 |
| TrulicityDulaglutide | 22 | $20,053 |
| OzempicSemaglutide | 21 | $19,205 |
| JardianceEmpagliflozin | 18 | $16,980 |
| EliquisApixaban | 18 | $15,635 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $11,553 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $10,472 |
| Potassium Chloride | 110 | $1,902 |
| Atorvastatin Calcium | 157 | $1,628 |
| Estradiol | 32 | $1,387 |
| Lisinopril | 157 | $1,359 |
| Losartan Potassium | 116 | $1,228 |
| Amlodipine Besylate | 135 | $1,157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $191 | $56,50757 claims |
| MerckJanuvia | $125 | $34,89241 claims |
| Johnson & JohnsonXarelto | $36 | $29,91628 claims |
| Novo NordiskOzempic | $154 | $19,20521 claims |
| PfizerEliquis | $71 | $15,63518 claims |
| GSKBreo Ellipta | $46 | $11,55320 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $100 | $10,47213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 205 medical providers in Kansas.
Other medical in Coffeyville
- Linly StevensOverland Park$111K
- Shana ArnholdShawnee$82K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
- Courtney SteneOverland Park$22K
- Janella DewittOverland Park$19K
- Walter DeanMission$16K
- Jason MengesWichita$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.